Organisation paid for research Program year 2021 Source: CMS Open Payments

New Vision Eye Center

Neither a doctor nor a teaching hospital

Research payments

$125,473

53 payments

Through program year 2021, New Vision Eye Center is reported as receiving $125,473 in research payments, across 53 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$34,929	18
2020	Research	$66,707	22
2019	Research	$23,836	13

Breakdown

Who paid Research payments · program years 2019–2021

Glaukos Corporation $94,896 50 payments
Novartis Pharmaceuticals Corporation $30,577 3 payments

Studies the money was for Research payments · program years 2019–2021

A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery $43,811 25 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $34,545 11 payments
A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab VS. Aflibercept in Patients With Visual Impairment Due to Diabetic MacUlar Edema (Kingfisher) $17,127 2 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $16,539 14 payments
A 96-Week, Two-Arm, Randomized, Single-Masked, Multi-Center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 MG Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy $13,450 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.